Streetbeat News

Stock Prices

ITI

Iteris, Inc. (NASDAQ:ITI) stock surged premarket Friday after Almaviva S.p.A. agreed to acquire the company in a $335 million all-cash deal. Iteris shareholders will receive $7.20 per share, a 68% premium over the closing price on August 8, 2024. The transaction, expected to close in 2024, will result in Iteris becoming privately held and delisted from Nasdaq. Iteris also reported better-than-expected Q1 FY25 earnings and reiterated its revenue guidance for FY25.

Portfolio Pulse from Lekha Gupta

August 09, 2024 | 10:40 am

EMBC

Embecta has reaffirmed its 2024 revenue guidance of $1.11 billion to $1.12 billion, which is in line with the consensus estimate of $1.115 billion.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:34 am

EMBC

Embecta reported Q3 2024 adjusted EPS of $0.74, which may not be comparable to the $0.46 estimate. Sales were $272.5 million, beating the $267.435 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:32 am

CHK

MUR

PSX

Wall Street's most accurate analysts have spotlighted three high-dividend-yielding energy stocks: Chesapeake Energy Corporation (CHK), Murphy Oil Corporation (MUR), and Phillips 66 (PSX). These stocks are favored for their high free cash flows and substantial dividend payouts. Analysts have provided various ratings and price targets for these stocks, with recent earnings reports and strategic moves also highlighted.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 10:29 am

GB

Global Blue reported a 12% growth in its Issued Sales In-Store for July in Continental Europe, indicating a positive trend in tax-free shopping.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:27 am

CRUZ

CRWD

DAL

JETS

MSFT

Delta Air Lines (NYSE:DAL) expects a $380 million revenue impact for the September quarter due to an outage caused by CrowdStrike (NASDAQ:CRWD), leading to 7,000 flight cancellations. Delta is pursuing legal claims against CrowdStrike and Microsoft (NASDAQ:MSFT) for damages totaling at least $500 million. The outage also resulted in $170 million in non-fuel expenses and a $50 million reduction in fuel expenses. DAL stock has lost around 12% in the last 12 months. Investors can gain exposure via U.S. Global Jets ETF (NYSE:JETS) and Defiance Hotel, Airline, and Cruise ETF (NYSE:CRUZ).

Portfolio Pulse from Lekha Gupta

August 09, 2024 | 10:16 am

AMRX

Amneal Pharmaceuticals has updated its 2024 adjusted EPS guidance to a range of $0.57-$0.63, up from the previous range of $0.53-$0.63. This new guidance is in line with the consensus estimate of $0.61.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:10 am

AMRX

Amneal Pharmaceuticals has raised its full-year 2024 guidance, expecting revenues between $2.70 billion and $2.80 billion, up from the prior guidance of $2.55 billion to $2.65 billion. The company also increased its adjusted EBITDA, adjusted diluted EPS, and operating cash flow projections.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:09 am

SATS

EchoStar reported its Q2 2024 financial results, with a GAAP EPS of $(0.76), missing the estimate of $(0.17). Sales were $3.953 billion, also missing the estimate of $3.983 billion.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:08 am

IMOS

ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS) reported a 12.4% year-over-year revenue growth for July 2024, driven by strong DDIC demand and improved inventory levels. The revenue for July 2024 was NT$2,063.4 million (US$63.1 million), marking a 7.6% increase from June 2024.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 10:06 am